MDS' sites "perfectly dovetail" with Ricerca's capacity; VP

The capabilities of the MDS Pharma Services' sites Ricerca is set to acquire "perfectly dovetail" with its existing capacity, according to a company vice president.

Speaking to Outsourcing-Pharma at Informex 2010, Mark Crane, vice president, business development and marketing at Ricerca, explained that services proivided by the MDS' sites take clients up to the developmental stage that Ricerca traditionally began working with companies.

Acquiring the MDS' sites increases Ricerca's headcount from 270 to over 800 and expands the company into new geographies. Despite this, Crane believes that integration will be relatively straightforward because of the lack of overlap between Ricerca's existing capacity and the acquired sites.